1. Home
  2. SABS vs FPAY Comparison

SABS vs FPAY Comparison

Compare SABS & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • FPAY
  • Stock Information
  • Founded
  • SABS 2014
  • FPAY 2003
  • Country
  • SABS United States
  • FPAY United States
  • Employees
  • SABS N/A
  • FPAY N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • SABS Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • SABS Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • SABS 15.8M
  • FPAY 18.3M
  • IPO Year
  • SABS N/A
  • FPAY N/A
  • Fundamental
  • Price
  • SABS $2.34
  • FPAY $0.42
  • Analyst Decision
  • SABS Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • SABS 4
  • FPAY 2
  • Target Price
  • SABS $9.50
  • FPAY $2.25
  • AVG Volume (30 Days)
  • SABS 481.4K
  • FPAY 915.6K
  • Earning Date
  • SABS 11-05-2025
  • FPAY 11-12-2025
  • Dividend Yield
  • SABS N/A
  • FPAY N/A
  • EPS Growth
  • SABS N/A
  • FPAY N/A
  • EPS
  • SABS N/A
  • FPAY N/A
  • Revenue
  • SABS $114,698.00
  • FPAY $139,800,732.00
  • Revenue This Year
  • SABS N/A
  • FPAY $19.71
  • Revenue Next Year
  • SABS N/A
  • FPAY N/A
  • P/E Ratio
  • SABS N/A
  • FPAY N/A
  • Revenue Growth
  • SABS N/A
  • FPAY 19.51
  • 52 Week Low
  • SABS $1.00
  • FPAY $0.27
  • 52 Week High
  • SABS $6.60
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • SABS 55.11
  • FPAY 31.71
  • Support Level
  • SABS $1.85
  • FPAY $0.27
  • Resistance Level
  • SABS $2.49
  • FPAY $0.68
  • Average True Range (ATR)
  • SABS 0.21
  • FPAY 0.07
  • MACD
  • SABS 0.01
  • FPAY -0.03
  • Stochastic Oscillator
  • SABS 47.00
  • FPAY 28.20

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: